- For patients & families
- For investigators
- Transparency & data sharing
In selecting trial sites, we pay careful attention to the expertise and training of the staff, the availability of patients, the regulatory frameworks of the host country, and several other critical factors.
If you are interested in learning more about our clinical programs and how you can get involved in our research, please contact us at ClinicalTrials@biogen.com.
Our mission is to improve the quality of patient care by supporting research that advances scientific knowledge of our products, and disorders of therapeutic relevance to Biogen.
- To learn more about our medical research, including investigator-initiated trials, please click here. The areas of research that are currently being considered to support studies related to general multiple sclerosis, prolonged-release fampridine, natalizumab, and peginterferon beta-1a, are also provided.
If you are interested in learning more about our clinical programs and how you can get involved in our research, please contact us at CTRC@biogen.com.